SUMMARY Four hundred and forty unrelated British Caucasoid patients with rheumatoid arthritis (RA) have been HLA typed for class I and class II antigens. Analyses of HLA antigen associations were performed on the overall group and in patient subsets selected according to particular disease parameters or sex, or both. The results confirm previously reported positive associations of HLA-DR4, Dw4, and DRw53 and negative associations of HLA-DR2 and DR7 with RA. Patients subsets with severe erosions, seropositivity, and features of extra-articular disease showed a stronger association, also confirming earlier reports. The link between HLA and disease severity was emphasised by a significant trend of increased Dw4 frequency with increasing severity of radiological erosions. In addition, a positive association of RA with HLA-A2 was observed and a strong negative association with DR3. The frequency of HLA-B27 was significantly increased in patients with subluxation of the spine. Differences were observed between male and female patients in relation to the HLA association. In men an increase in the frequency of the haplotype HLAIDw4/DR4/Bw62/Cw3/A2 was observed. This showed no relationship with parameters of disease severity other than extra-articular disease. In women only class II antigens (DRw53/Dw4/DR4) showed an increased frequency. This increase was strongly associated with disease severity. A significant decrease of this class II association was observed with increasing age of disease onset; this was not seen in men.
Rheumatoid arthritis (RA) is a relatively common condition, of which the aetiology remains unknown and the basis for susceptibility in individuals is still unclear. A major advance in our understanding of RA development came with the observation that certain HLA antigens were strongly associated with this disease. These antigens include HLA-Dw4l DR4,2 and DRw53 (MT3).3 No association with HLA-A or B locus antigens was found in the early studies,4 5 though several later reports suggested other HLA antigen associations. 6 In most of the reported studies the frequency of DR4 in RA patients is within the range 50-75%, Accepted for publication 30 January 1986. Correspondence to Dr D Jaraquemada, Department of Immunology, The London Hospital Medical College, 56-76 Ashfield Street, London El 2BL. whereas the frequency of DR4 in controls ranges between 25% and 35%. Such association argues for the existence of an RA predisposing factor which is cotransmitted (linked) or associated with HLA. This factor could be DR4 itself or a component of susceptibility in linkage disequilibrium with HLA-DR4. These findings must be interpreted in the context of the known familial tendency to develop RA. In the number of small family studies which have been performed, however, the evidence for nosological entity. The clarification of the relation between all components involved in the disease, including HLA, could help to resolve this question.
In the studies of HLA and disease three observations must be made in relation to the interpretation of any results. The first is that the patient sample size can limit the confidence placed on any observation. Secondly, most reports of adequate sample size have usually been from international collaborative studies involving heterogeneous HLA results from different laboratories. The third is that any comparisons require homogeneity of ethnic origin between both patient and control panels. This is important because of the varying distribution of HLA polymorphisms in different populations. This lack of homogeneity may be a valid criticism of a number of international collaborative studies. In this report attempts to overcome these three problems have been made.
In the past six years a total of 440 Caucasoid RA patients of British ancestry (British Caucasoids) have been HLA typed in the Department of Immunology of The London Hospital Medical College. The patients were attending different centres but were all part of various collaborative studies of HLA and RA. This large sample of RA patients is homogeneous with respect to both ethnic origin of the population studied and the quality control of all the HLA typing. We have now pooled all these data in order to re-examine several findings reported before by ourselves and other groups of investigators.
Patients and methods

PATI ENTS
Four hundred and forty unrelated British Caucasoid RA patients from several groups have been studied. The patient selection criteria and the distribution of these patients in the different study groups are shown in Table 1 ., I. Table 2 .
The relation between the frequency of specific antigens and indices of disease severity which could be expressed on an ordinal scale were analysed by Kendall's tau (T), which gives an indication of linear trend between two variables. 20 The effect of age at onset was described by examination of 10 year moving averages; the raw data (of presence or absence of specific antigen) were examined for linearity by regression techniques. The parameter b (linear regression coefficient) was calculated. Table 2 shows the HLA antigens with significant positive or negative associations with RA in the total panel of 440 patients and in each of the single groups of patients studied. The frequencies of HLA-DR4, Dw4, and DRw53 were significantly increased. The relative risk (RR) and the aetiological fraction (EF) were greater for DR4 (RR=4.09, EF=0-49) than for Dw4 (RR=2-8, EF=0.31) and DRw53 (RR=2-0, EF=035).
Results
HLA ANTIGENS IN EACH PATIENT GROUP AND IN THE OVERALL RA-PANEL
Other HLA-DR antigens showed significantly lower frequencies in the RA patients compared with controls: DR2 (RR=0-54*, EF=0-12), DR3 (RR=0-38***, EF=0.21), and DR7 (RR=0-43**, EF=0.16).
The class I antigens with significantly different frequencies in the RA patients compared with the control panel were A2, Al, and B18. HLA-A2 was significantly increased (RR=1.64*, EF=0-23), and Al and B18 were found with lower frequencies (RR=0-60*, EF=0-14 and RR=0.31**, EF=0-08 respectively).
HLA ASSOCIATION WITH RA IN MALE AND FEMALE PATIENTS
The overall frequency of DR4 in male and female patients was very similar (64-8% in men and 65-6% in women) ( Table 3 ). There were some differences for other antigens, however: the frequencies of HLA-A2, Cw3, and Bw62 were significantly increased in male patients but not in the female RA patients compared with controls. No significant difference in HLA antigen frequency was seen between male and female controls.
HLA AND AGE OF ONSET OF RA
The proportion of patients with DR4 was analysed by age at disease onset for male and female patients. Results are presented in Fig. 1 Age of disease onset and 83 (20-3%) seronegative (Table 4 ). The frequency of DR4 was significantly raised in both seropositive and negative patients compared with controls. Dw4 and DRw53, however, were significantly raised only in the seropositive patients. The frequency of HLA-Bw6O was significantly higher in the negative patients than in controls. A comparison of the seropositive and negative panels showed that the frequencies of DR4, Dw4, and DRw53 were significantly higher in the former group, whereas that of Bw6O was significantly higher in the latter.
The frequency of DR4 and A2 was significantly raised in both seropositive and negative male patients compared with non-RA controls. The frequencies of DRw53, Dw4, and Bw62 were also increased in seropositive men, and those of Bw6O and Cw3 in seronegative men. In the seropositive Table 2 ).
female patients only DR4, Dw4, and DRw53 had non-erosive group to 74-4% in the severe group. raised frequencies and only DR4 and Bw6O were HLA-Dw4 increased from 40% to 66% in the same increased in the seronegative female patients. groups and that of DRw53 from 62-2% to 77-7%. When seropositive and negative men were com-The trend of increase of the Dw4 frequency with the pared with each other the only difference was that severity of the erosions was significant (Kendall's the frequency of A2 was significantly raised in the tau=0-22, p<005). The trend for DR4 and DRw53 negative group. A comparison of seropositive and did not reach significance. The results were different seronegative women, however, shows that the fre-in the two sexes. quencies of DR4, Dw4, and DRw53 were signifi-A significant trend of increased frequency of each cantly increased in the positive group, and that of of the antigens Dw4, DR4, and DRw53 with increasBw6O was increased in the seronegative female ing severity of erosions was seen in women only patients.
(T=0-29, p<005 for Dw4, T=0-27, p<0-01 for DR4, and T=0-28, p<0.01 for DRw53). No significant HLA AND RADIOLOGICAL CHANGES differences were observed for any antigen in relation Radiological data of the hand and feet were avail-to the severity of erosions in the male patients. able'on 218 patients, of which 45 were non-erosive, Subluxations of the cervical spine were studied in 43 had mild erosions, 85 moderate, and 45 severe 167 patients, of which 105 had none, and 62 had erosions; 79-36% of the total tested panel had subluxation (Table Sb) . The frequency of DR4 in erosions to some degree. Table Sa shows the DR4 those patients with and without subluxations was and Dw4 frequencies in the different groups. The significantly different from that of the non-RA frequency of DR4 increases from 57-1% in the controls. The frequency of HLA-B27 was signifi- Table 2 ).
cantly increased in the patients with subluxation compared with controls (RR=2-42*, EF=015). When patients with and without subluxations were compared no differences in the frequencies of DR4, DRw53, and Dw4 were seen, though significantly higher frequency of B27 was found in the positive group (RR=4.4**). The p values, however, have not been corrected for the number of comparisons made and must therefore be confirmed by other studies.
HLA IN OTHER RA SUBSETS (TABLE 6) Subcutaneous nodules The frequencies of DR4, Dw4, and A2 were higher in patients with subcutaneous nodules, when compared with patients without nodules. These differences did not reach statistical significance.
Extra-articular disease HLA-DR4, Dw4, Bw62, Cw3, and A2 were all more frequent in the patients with extra-articular manifestations other than nodules (n=35) compared with those without any extra-articular disease (n=282). The comparison between these two groups showed significant differences in the frequencies of Bw62 and Cw3, which were raised in the positive patients. 30 An overall association between DR4, Dw4, and DRw53 and RA severity is confirmed by our data. We have observed a significant trend between the increased severity in erosions of the hand and feet and the raised DR4/Dw4/DRw53 frequency. The trend for HLA-Dw4 is particularly clear, thus confirming and extending our previous study. 25 A significantly higher frequency of DR4, Dw4, and DRw53 was found in seropositive RA patients when compared with seronegative ones. The difference in DR4 frequency was relatively small (12.5%, 98% confidence interval 7.7-17-3%). This might explain the apparently contradictory results reported from smaller series. 31 32 In our analysis seropositive data from two different tests (latex and RAHA) have been pooled. Furthermore, seropositivity can be a somewhat transient feature of RA, with a proportion of false negatives being expected at any time. Both these factors may contribute to the heterogeneity of the data. In each group of data, however, seropositive patients had a consistently higher frequency of DR4/Dw4/DRw53 than that in the seronegative group. Additionally, pooling such heterogeneous data is likely to mask any differences found, and thus the real significance of our finding may be underestimated.
An interesting result in the analysis of the seronegative patients was the association found with DR4/Bw6O but not with Dw4. It is well known that this particular haplotype is associated in Caucasoids with the Dw14 specificity.33 It is therefore most likely that an association exists between this subset of the disease and the haplotype Dw14/DR4/Bw6O. Although only a small number of patients were tested for the Dw14 specificity, it is interesting to note that the two Dw14 positive patients were both seronegative. Obviously these data are too limited to presume such an association, but they are an indication that it may exist. A further study of this specificity in seronegative patients would be of interest.
Although there are no absolute diagnostic criteria for RA, a firm diagnosis becomes more likely when the disease is more severe. The more homogeneous groups of severe patients in this study showed a stronger HLA association with the disease than that observed in the early diagnosed patients. This shows the importance of patient selection for any study of HLA and RA. This could also be a reflection of a possible association of HLA with RA severity. It is therefore hard to distinguish between either an HLA link with disease susceptibility or disease severity, particularly when the patient groups studied are small or highly selected. The results of our analysis suggest that DR4 may be associated with overall RA susceptibility since an association with DR4 is seen in all subsets of patients. Furthermore, the presence of Dw4 and DRw53 in addition to DR4 appears to be associated with parameters of disease severity such as the presence of nodules and other extra-articular manifestations, erosions, and seropositivity.
The relation between the HLA status and the presence of subluxation of the cervical spine was interesting and has not previously been noted. The frequencies of DR4, Dw4, and DRw53 were not different between patients with and without subluxations. Some consider rheumatoid neck involvement occurs with the most severe disease; Rasker and Cosh, however, found that the presence of cervical subluxations was related more to the response to corticosteroid treatment than to the severity of the disease as a whole.34 A significant increase of the frequency of HLA-B27 in the patients with subluxation was observed. An association of B27 has been suggested in patients with 'juvenile arthritis, when the spine is involved'. 28 Our data now show much clearer HLA differences between male and female patients. Female patients follow the pattern seen for the overall group, i.e., high frequencies of DR4, Dw4, and DRw53, which increase in seropositive patients and in patients with erosions. In contrast, the pattern of HLA frequency distribution observed in the male patients is very different: in addition to DR4, DRw53, and Dw4, the frequencies of A2, Cw3, and Bw62 were also significantly raised. No differences between seropositive and seronegative male patients were observed, and there was no increase of the frequency of any HLA antigen in relation to the degree of erosions.
Further, the relation of HLA status and age of disease onset was different in men and women, with a decrease in DR4 frequency with increasing age of onset in women. This difference was not observed for seropositivity. No relation to the HLA status was found with the age of disease onset in the male patients.
The observations that more women than men develop RA but both show a significant increase of DR4 frequency suggest a major susceptibility factor other than HLA in female patients. This could be a hormonal factor, and it appears to be less operative in younger women. It could also be an additional genetic factor which is less operative in younger women due to some hormonal component/s. This could explain why in younger women a higher HLA association is observed, indicating the necessity of a stronger genetic component in order to develop the disease. As the woman ages this hormonal protection becomes less operative and the HLA association becomes less necessary. A possible protective factor against the development of the disease may also exist in men, where it may be overcome by a stronger genetic component (A2/Bw62/DR4). Interestingly, the age of onset of male patients does not appear to have any effect on this factor, and the association with HLA is as strong for the male patients irrespective of age of onset.
We interpret the increase of DR4/Dw4/DRw53/ Bw62/Cw3/A2 as a further confirmation of an HLA haplotype being associated with RA in men. These antigens are in linkage disequilibrium with each other in Caucasoid populations. 35 The possibility therefore exists that the high frequency of these antigens may be merely a result of the 'hitch hiking' effect due to their linkage disequilibrium with DR4.42 However, DR4 is also in strong linkage disequilibrium with B44 and Bw6O35 and with the DwlO, Dw13, and Dw14 antigens in Caucasoids.13 33 These antigens are not significantly raised in this group of male RA patients, suggesting that this particular haplotype is significantly implicated in the development of RA in men. In addition, the demonstration of a significant association between RA and HLA-A2 principally in men requires careful consideration. Although there is some linkage disequilibrium between A2 and DR4 in Caucasoids,35 this is weak and cannot explain the extremely high increase of the combined frequency of both A2+DR4, which is 46% in the patients compared with 18% in the controls. This A2+DR4 association is higher in men (combined antigen frequency of 55%) than in female RA patients (42%). Furthermore, although the combined relative risk of A2+DR4 in the total RA panel is not higher (RR=3.37) than for DR4 alone (RR=4-0), it is higher than that for A2 alone (RR= 1-6). In male RA patients the RR for A2+DR4 is 4-73, whereas the RR for DR4 alone is 3-97, and 2-8 for A2.
These data confirm that HLA is more important for the development of RA in men than in women. This difference appears to be the inferred presence of an HLA 'haplotype' DR4/Dw4/DRw53/Bw62/ Cw3/A2 in Caucasoids. The 'haplotype' found in Japanese patients was Dw15/DR4/DRw53/Bw54. This appears to be due to a possible preferential allelic association of the disease with these particular antigens, rather than to linkage disequilibrium.
A multifactorial cluster analysis is now being carried out on these data in an attempt to subdivide the disease according to HLA status in addition to the clinical data. 
